Exelixis raises $71.8 million through stock offering

South San Francisco-based biotechnology company Exelixis Inc. (EXEL) said it has netted approximately $71.8 million through its public offering of 7 million shares of common stock.

Underwriter Goldman, Sachs & Co. has also been granted a 30-day option to purchase up to an additional 1.05 million shares of common stock.

A.J. Jacobs thinks the meaning of life can be found in puzzles

New book “The Puzzler” embraced by San Francisco crossword, jigsaw and chess wizards

Warriors vs. Mavericks preview: Another series, another super-hero

Round after round, Golden State has faced the NBA’s best. Next up, Luka Dončić

Laguna Honda struggles with recertification efforts

The relocation plan is the latest development in a string of troubling milestones for Laguna Honda